204 related articles for article (PubMed ID: 34755037)
1. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
[TBL] [Abstract][Full Text] [Related]
2. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
[TBL] [Abstract][Full Text] [Related]
4. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
[TBL] [Abstract][Full Text] [Related]
5. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations.
Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040
[TBL] [Abstract][Full Text] [Related]
6. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors.
Shaffer SR; Kuenzig ME; Windsor JW; Bitton A; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Tandon P; St-Pierre J; Natt N; Davis T; Weinstein J; Im JHB; Benchimol EI; Kaplan GG; Goddard Q; Gorospe J; Bergevin M; Silver K; Bowles D; Stewart M; Pearlstein M; Dawson EH; Bernstein CN
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S45-S54. PubMed ID: 37674503
[TBL] [Abstract][Full Text] [Related]
7. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
[TBL] [Abstract][Full Text] [Related]
8. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications.
Targownik LE; Bernstein CN; Lakatos PL; Murthy SK; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Jones JL; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Windsor JW; Panaccione R
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S40-S45. PubMed ID: 34755038
[TBL] [Abstract][Full Text] [Related]
9. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life.
Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039
[TBL] [Abstract][Full Text] [Related]
10. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
[TBL] [Abstract][Full Text] [Related]
11. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over Time.
Coward S; Windsor JW; Kuenzig ME; Bitton A; Bernstein CN; Jones JL; Khanna R; Lee K; Murthy SK; Targownik L; Benchimol E; Huang JG; Mukhtar MS; Tandon P; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S20-S26. PubMed ID: 34755035
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
[TBL] [Abstract][Full Text] [Related]
13. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.
Roy S; Sheikh SZ; Furey TS
Sci Rep; 2021 Aug; 11(1):16522. PubMed ID: 34389789
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
Tepasse PR; Vollenberg R; Nowacki TM
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
[TBL] [Abstract][Full Text] [Related]
15. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
[TBL] [Abstract][Full Text] [Related]
17. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.
Jones JL; Benchimol EI; Bernstein CN; Huang JG; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Kaplan GG; Kuenzig ME; Tandon P; Targownik LE; Windsor JW; Bitton A
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S61-S67. PubMed ID: 34755041
[TBL] [Abstract][Full Text] [Related]
18. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040
[TBL] [Abstract][Full Text] [Related]
19. Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
Amiot A; Bourrier A; Gornet JM; Dewit O; Nancey S; Altwegg R; Abitbol V; Laharie D; Reenaers C; Gagnière C; Buisson A; Nachury M; Viennot S; Vuitton L; Stefanescu C; Marteau P; Bouguen G; Seksik P;
Infect Prev Pract; 2023 Mar; 5(1):100267. PubMed ID: 36601289
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL
Can J Gastroenterol Hepatol; 2021; 2021():7591141. PubMed ID: 34858891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
